Adapted Dialectical Behavior Therapy for Suicide Risk
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests an adapted form of Dialectical Behavior Therapy (a type of talk therapy) to reduce suicidal thoughts in family caregivers of individuals with Alzheimer’s or related dementias. The goal is to develop a program specifically for those experiencing high stress and emotional burden from caregiving. It targets primary caregivers living with someone diagnosed with these conditions who have shown signs of suicidal risk. As an unphased trial, this study allows caregivers to contribute to developing a potentially life-changing therapy tailored to their unique needs.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this therapy is safe for aging adult family caregivers?
Research has shown that Dialectical Behavior Therapy (DBT) is generally safe for individuals with suicidal thoughts. One study demonstrated that a shorter 26-week DBT program reduced suicidal thoughts and attempts in autistic adults, indicating its effectiveness for people with complex needs.
Another study found that DBT reduced self-harm and suicide attempts in highly suicidal teenagers, supporting its safety across different age groups.
While results can vary, DBT consistently proves safe and effective in lowering suicidal risks. These studies suggest that DBT is a safe option for those considering it, including family caregivers of individuals with Alzheimer's Disease and Related Dementias.12345Why are researchers excited about this trial?
Researchers are excited about Adapted Dialectical Behavior Therapy (DBT) because it specifically targets suicide ideation among family caregivers of individuals with Alzheimer's Disease and Related Dementias (AD/ADRD), which is a unique focus not commonly addressed by standard treatments. Unlike traditional DBT, which is used for a variety of mental health issues, this adapted version hones in on the intense emotional stress and potential suicidal thoughts experienced by these caregivers. By customizing the therapy to address the specific challenges faced by this group, it offers a tailored approach that could lead to more effective outcomes in reducing suicide risk, something current general mental health therapies may not adequately achieve.
What evidence suggests that Adapted Dialectical Behavior Therapy might be an effective treatment for reducing suicidality in caregivers of persons with Alzheimer's Disease?
Research has shown that Dialectical Behavior Therapy (DBT) reduces outcomes related to suicide. Studies consistently find that DBT lowers the number and seriousness of suicide attempts and suicidal thoughts. A review of multiple studies confirmed DBT's effectiveness in reducing suicidal behavior. While most research focuses on teenagers and adults at high risk of suicide, these findings suggest DBT can also help different groups, including those in stressful caregiving roles. This trial will specifically test an Adapted Dialectical Behavior Therapy, focusing on reducing suicide ideation for family caregivers of persons with Alzheimer's Disease and Related Dementias. Overall, DBT has demonstrated strong results in reducing suicidality, making it a promising option for caregivers.56789
Are You a Good Fit for This Trial?
This trial is for adults over 50 who are primary caregivers for someone with Alzheimer's or related dementias. Participants must show signs of suicide risk, speak English fluently, and be willing to provide blood samples. It's not suitable for those who don't meet the suicide risk criteria.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Adaptation and Implementation
Adaptation of DBT skills training for family caregivers, followed by implementation of the adapted DBT skills training groups
Follow-up
Participants are monitored for safety and effectiveness after treatment, including self-report assessments and focus groups
What Are the Treatments Tested in This Trial?
Interventions
- Adapted Dialectical Behavior Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Texas Tech University
Lead Sponsor